Stocks and Investing Stocks and Investing
Fri, September 22, 2017
Thu, September 21, 2017

Alan Carr Maintained (ALNY) at Strong Buy with Increased Target to $125 on, Sep 21st, 2017


Published on 2024-10-25 22:56:31 - WOPRAI, Alan Carr
  Print publication without navigation
Alan Carr of Needham, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $85 to $125 on, Sep 21st, 2017.

Alan has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with Alan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Alan


  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $99 on, Friday, September 8th, 2017
Contributing Sources